A new study reveals that popular diabetes and weight-loss drugs like Ozempic and Wegovy may not work as effectively for about ...

Subscribe to The Post Most newsletter for the most important and interesting stories from. Korrie Stevenson had been feeling ...

More than one in four people with Type 2 diabetes use GLP-1 receptor agonists, a class of widely prescribed medications. However, new research from ...

Public school teachers in Illinois may soon have to add Latin Americans to the list of ethnic groups whose contributions to ...

Next, Classes II to V performed, their emcee were Ananya Arora and Gargi Chatterjee of Class XI. The school band spiced up ...

Python-derived pTOS shows promise as a side-effect-free appetite suppressant, offering a new path for weight loss and metabolic therapies.

From yoga and art workshops to online communities and dark humor, Israelis are building new emotional lifelines.

Read more: 20 albums that paved the way for alternative as we know it ...

Good morning, and welcome to the Akebia Therapeutics R&D Day. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be made available on the Akebia website following ...

In addition to the artificially induced LSD state, there are other, naturally occurring temporary states in which there is a collapse of the normal routines by which the mind ordinarily processes the ...

For the past 7 years, pharmaceuticals that work as glucagon-like peptide 1 (GLP-1) receptor agonists have dominated the weight-loss and diabetes markets. These drugs, currently so ...

There is a food that has been shown in multiple human randomized controlled trials to improve metabolic health, reduce liver fat, and even drive weight loss independent of calorie intake.